Ceftazidime pentahydrate, 95%

Name: Ceftazidime pentahydrate, 95%
SKU: J66460.03

CAS: 78439-06-2 | C22H32N6O12S2 | 636.648 g/mol

テクニカルサポートオーダーサポート

表示を変更

数量:

1 g

5 g

Chem dex^TM Webアプリをお試しください

製品番号（カタログ番号） J66460.03

または、製品番号J66460-03

価格（JPY）

数量:

1 g

一括またはカスタム形式をリクエストする

化学物質識別子

CAS78439-06-2

IUPAC Name1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1,2-dihydropyridin-2-ylium pentahydrate

Molecular FormulaC22H32N6O12S2

InChI KeyNMVPEQXCMGEDNH-TZVUEUGBSA-N

SMILESO.O.O.O.O.CC(C)(ON=C(/C(=O)N[C@H]1[C@H]2SCC(CN3[CH+]C=CC=C3)=C(N2C1=O)C([O-])=O)C1=CSC(N)=N1)C(O)=O

さらに表示

仕様

スペックシート

Appearance (Color)White to off-white

FormPowder or crystals or crystalline powder

Loss on Drying13.0-15.0%

Assay from Supplier's CofA≥94.0%

Ceftazidime pentahydrate is an antibacterial agent. It is used especially for Pseudomonas and other gram-negative infections in debilitated patients. It is used in the treatment of patients with infections caused by susceptible strains of organisms in the following diseases: lower respiratory tract infections,skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra abdominal infections (including peritonitis), and central nervous system infections (including meningitis).

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Solubility
Sparingly soluble in aqueous solution

Notes
Research Use only: Not intended for animal or human diagnostic or therapeutic use.

RUO – Research Use Only

General References:

Borys Snopok; Ivanna Kruglenko. Analyte induced water adsorbability in gas phase biosensors: the influence of ethinylestradiol on the water binding protein capacity. Analyst (Cambridge UK).2015, 140, (9), 3225-3232.
A Adu; C L Armour. Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime. Drugs.1995, 50, (3), 423-439.